Filtrer vos résultats
- 3
- 3
- 3
- 3
- 3
- 2
- 1
- 1
- 1
- 3
- 3
- 3
- 3
- 2
- 2
- 2
- 2
- 2
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
- 1
|
|
triés par
|
|
DESCRIPTION IN REAL-WORLD OF THE EFFICACY AFTER SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ADMINISTRATION OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. THE ROSWITCH STUDYAnnals of the Rheumatic Diseases, 2018, 77 (2), pp.1384-1385. ⟨10.1136/annrheumdis-2018-eular.3411⟩
Article dans une revue
hal-03606085v1
|
||
|
BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PSORIATIC ARTHRITIS: A REAL-WORLD COHORT OF 439 PATIENTSAnnals of the Rheumatic Diseases, 2018, 77 (2), pp.373. ⟨10.1136/annrheumdis-2018-eular.4980⟩
Article dans une revue
hal-03606086v1
|
||
|
THERAPEUTIC MAINTENANCE OF ABATACEPT IN RHEUMATOID ARTHRITIS: RESULTS OF THE RIC-ABA STUDY (517 PATIENTS)Annals of the Rheumatic Diseases, 2018, 77 (2), pp.1385. ⟨10.1136/annrheumdis-2018-eular.4440⟩
Article dans une revue
hal-03606087v1
|